lupin surges on getting tentative usfda approval for mirabegron extended release tablets
Lupin

Lupin is currently trading at Rs. 1073.45, up by 37.60 points or 3.63% from its previous closing of Rs. 1035.85 on the BSE.

The scrip opened at Rs. 1030.40 and has touched a high and low of Rs. 1078.00 and Rs. 1011.10 respectively. So far 215429 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 2 has touched a 52 week high of Rs. 1078.00 on 04-Aug-2023 and a 52 week low of Rs. 602.80 on 04-Aug-2022.

Last one week high and low of the scrip stood at Rs. 1078.00 and Rs. 971.85 respectively. The current market cap of the company is Rs. 48162.83 crore.

The promoters holding in the company stood at 47.07%, while Institutions and Non-Institutions held 43.30% and 9.64% respectively.

Lupin has reported over 4-fold jump in its net profit at Rs 476.96 crore for the first quarter ended June 30, 2023  as compared to Rs 117.18 crore for the same quarter in the previous year. Total income of the company increased by 28.64% at Rs 3,523.38 crore for Q1FY24 as compared Rs 2,738.97 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net profit of Rs 452.26 crore for the first quarter ended June 30, 2023 as compared to net loss of Rs 89.08 crore for the same quarter in the previous year. Total income of the company increased by 29% at Rs 4,836.89 crore for Q1FY24 as compared Rs 3,749.40 crore for the corresponding quarter previous year.